Subjective cognitive decline is a better marker for future cognitive decline in females than in males.

ABSTRACT:

Background

The identification of biomarkers for early detection of Alzheimer's disease (AD) is critical to the development of therapies and interventions targeted at symptom management and tracking the pathophysiology of disease. The endorsement of subjective cognitive decline (SCD) has emerged as a potential indicator of early change in cognitive status that may be predictive of future impairment at a time when measurable declines in neuropsychological performance cannot be detected. While there are numerous findings revealing sex differences in the prevalence of AD, there is a paucity of research examining sex differences in SCD. Therefore, the goal of this project was to determine if the relationship between the endorsement of SCD and future cognitive changes differ as a functio

SUBMITTER: Oliver MD 

PROVIDER: S-EPMC9798694 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature